about
Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomachExtended versus limited lymph nodes dissection technique for adenocarcinoma of the stomachCurrent status of function-preserving surgery for gastric cancerAppropriateness and diagnostic yield of upper gastrointestinal endoscopy in an open-access endoscopy system: a prospective observational study based on the Maastricht guidelines.Age, symptoms and upper gastrointestinal malignancy in primary care endoscopy.Improving the detection rate of early gastric cancer requires more than open access gastroscopy: a five year studyGastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia.Endoscopic submucosal dissection for undifferentiated-type early gastric cancer: do we have enough data to support this?Chemotherapy as a component of multimodal therapy for gastric carcinomaAn evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.Significance of a positive oesophageal margin in stomach cancer.Guidelines for dyspepsia management in general practice using focus groups.Why do dyspeptic patients over the age of 50 consult their general practitioner? A qualitative investigation of health beliefs relating to dyspepsiaUrgent cancer referral guidelines: a retrospective cohort study of referrals for upper gastrointestinal adenocarcinoma.Preservation of the spleen improves survival after radical surgery for gastric cancer.Survival trends in gastric cancer patients of Northeast China.Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy.Audit of a nurse endoscopist based one stop dyspepsia clinicSpiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging.Peritoneal cytology in the surgical evaluation of gastric carcinoma.Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative GroupTime trends of surgical treatment and the prognosis for Japanese patients with gastric cancer.Influence of pathological tumour variables on long-term survival in resectable gastric cancer.Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma.Gastric cancer surgery--a balance of risk and radicalityExtended lymphadenectomy in gastric cancer: when, for whom and whyClinical gastroenterology.Workload and resource implications of upper gastrointestinal cancer surgical centralisation in South East Wales.Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?DWI as a Quantitative Biomarker in Predicting Chemotherapeutic Efficacy at Multitime Points on Gastric Cancer Lymph Nodes Metastases.Predictive factors for local recurrence and incomplete resection of early gastric cancer treated by endoscopic resection: a Western experience.Pre-operative chemotherapy for gastric cancer.Optimal surgery for advanced gastric cancer.Long-term survival after gastrectomy for cancer in randomized, controlled oncological trials: comparison between West and East.Function-preserving gastrectomy for early gastric cancer.Gastroenterology--I: Gastroduodenal disease and Helicobacter pyloriGastric cancer: texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker.Value of routine, non-targeted biopsies in the diagnosis of gastric neoplasia.Oesophageal and gastric cancer pathology reporting: a regional audit.Extended lymph node dissection (D2 resection) should now be performed routinely in the curative surgical treatment of gastric carcinoma.
P2860
Q24203921-211CBAC8-5ADE-403F-8D38-E43CDFE7D7C9Q24247667-18034417-D4F2-454C-AE64-518CF952C414Q26852082-B43F4D88-7082-474D-9C99-209BE76968DFQ30482287-118FE733-42C0-4BD7-ACA7-A49F679E16D1Q30483964-E4BC753F-A5D2-482A-AAEB-F862CA6253FEQ30492448-770E342F-C609-4EEA-AA45-3124E23D5FE8Q30492453-58555643-E903-4F6B-BDB3-CF5170A625A0Q30803711-3E20E205-A65A-483D-9CC3-7E0DC12AB3A0Q33867249-9DCAE82A-1875-433E-A13F-C0583E06B023Q33952311-49AE00FD-220E-4576-9A53-30FE5A9BA9ACQ34054662-7776221E-41C7-47D5-B773-7DBE72EA9473Q34214546-0495F8C1-4601-40B9-8CE6-7120BF3001C6Q34215592-EA97C7E9-F237-45A1-942B-163E395F4D8DQ34247755-C5EEDE70-8470-4571-82C6-93380DF78026Q34408264-E1A344BC-FB2C-4157-95EC-5D64669548B2Q35171558-30DEE984-DA74-4469-9F3B-F4E9F46137C6Q35359543-5C324754-B24A-441C-B507-3FB73F879785Q35513597-F0A5261F-D2BB-4221-A68B-15F1EDA45D72Q35841026-9432C259-762C-439B-93AE-57004E9FBD4CQ36618135-CC2A993B-26F4-46F9-BF04-49163A71566BQ36619190-FA8EE366-093D-4A9D-9094-8C09DF3552BAQ36621969-F4811026-9FB5-449E-9ED0-0DB8589C0E61Q36644170-8C44C743-8A8A-4463-8D78-F59D6336EEEEQ36694121-74A6E4A6-FA4C-4364-BF5F-572276616E9AQ36725937-D7332DED-8DDB-4957-88E5-B477255E8B6EQ36821266-8CAB7870-79B7-46A4-AB54-C45BC5BCA627Q36901907-DAA33452-9781-4F06-B3C3-E683B02D9E83Q37108313-4E816008-0F0B-4178-8BEE-E94E98C7CC9EQ37156639-78EFCBBE-AF23-4D3C-AE07-02E2F3E6AADCQ37205927-8E9BA767-2191-4BB6-9FA1-84BAB9C9EB28Q37252841-860595C0-516B-4EC4-8BD8-822D736164D6Q37636574-7AA79090-DCA3-4127-AE5A-B44D86673FE7Q37642804-F07105E8-F847-453E-A0E1-CFD44F962BC3Q38076028-83B9A08A-18A3-43B3-AE68-E90F11BA42FFQ38090513-46AA18F1-5453-461D-AAFE-FF2DCBAA4BDFQ38633463-CEA52AD0-D15F-413B-A85F-2758EBA4FE02Q38935234-1B8AFAC7-6218-4215-BBAB-8F7FE734618AQ39579479-D8C92A08-828E-4201-9276-03D4123EA479Q39617804-AD7A083B-1571-406F-8AC1-C93C91A21B21Q40934327-86CA20A5-40E2-4D15-8E06-365B928C30B0
P2860
description
1993 nî lūn-bûn
@nan
1993 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Gastric cancer: a curable disease in Britain
@ast
Gastric cancer: a curable disease in Britain
@en
type
label
Gastric cancer: a curable disease in Britain
@ast
Gastric cancer: a curable disease in Britain
@en
prefLabel
Gastric cancer: a curable disease in Britain
@ast
Gastric cancer: a curable disease in Britain
@en
P2093
P2860
P356
P1433
P1476
Gastric cancer: a curable disease in Britain
@en
P2093
Johnston D
Lansdown MR
McMahon MJ
Sue-Ling HM
P2860
P304
P356
10.1136/BMJ.307.6904.591
P407
P577
1993-09-01T00:00:00Z